Published in Vaccine Weekly, March 15th, 2000
"To develop an HIV-1 vaccine with global efficacy, it is important to identify and characterize the viruses that are transmitted, particularly to individuals living in areas of high incidence," wrote E.M. Long and colleagues, Fred Hutchinson Cancer Research Center, Washington, USA. "Several studies have shown that virus from the blood of acutely infected adults was homogeneous, even when the virus population in the index case was genetically diverse."
Long et al. published their study in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly